Prevention of ventilator-associated pneumonia

Expert Review of Anti-Infective Therapy

Volumn 8, Issue 7, 2010, Pages 791-800

  Klompas, Michael ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Healthcare acquired infections; Infection prevention; Infection surveillance; Quality improvement; Ventilator associated pneumonia

Indexed keywords

ANTIINFECTIVE AGENT; CHLORHEXIDINE; ISEGANAN; POVIDONE IODINE;

ARTIFICIAL VENTILATION; BACTERIUM CONTAMINATION; ENDOTRACHEAL TUBE; EXTUBATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH CARE QUALITY; HUMAN; INTENSIVE CARE UNIT; MORBIDITY; MORTALITY; NONHUMAN; PATIENT POSITIONING; REVIEW; RISK ASSESSMENT; VENTILATOR ASSOCIATED PNEUMONIA;

DISINFECTION; EARLY DIAGNOSIS; HUMANS; INTUBATION, INTRATRACHEAL; PATIENT POSITIONING; PNEUMONIA, VENTILATOR-ASSOCIATED; SILVER;

EID: 77954238258     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.10.59     Document Type: Review

References (95)

1. Rello J, Quintana E, Ausina V et al. Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest 100(2), 439-444 (1991).
2. Tejerina E, Frutos-Vivar F, Restrepo MI et al. Incidence, risk factors, and outcome of ventilator-associated pneumonia. J. Crit. Care 21(1), 56-65 (2006).
3. Fagon JY, Chastre J, Vuagnat A, Trouillet JL, Novara A, Gibert C. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 275(11), 866-869 (1996).
4. Nguile-Makao M, Zahar JR, Francais A et al. Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at icu admission and vap onset using conditional logistic regression and multi-state models. Intensive Care Med. 36(5), 781-789 (2010).
5. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials group. Am. J. Respir. Crit. Care Med. 159(4 Pt 1), 1249-1256 (1999).
6. Muscedere JG, Martin CM, Heyland DK. The impact of ventilator-associated pneumonia on the canadian health care system. J. Crit. Care 23(1), 5-10 (2008).
7. Melsen WG, Rovers MM, Bonten MJ. Ventilator-associated pneumonia and mortality: a systematic review of observational studies. Crit. Care Med. 37(10), 2709-2718 (2009).
8. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit. Care Med. 33(10), 2184-2193 (2005).
9. Beyersmann J, Gastmeier P, Grundmann H et al. Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection. Infect. Control Hosp. Epidemiol. 27(5), 493-499 (2006).
10. Warren MM, Gibb AP, Walsh TS. Antibiotic prescription practice in an intensive care unit using twice-weekly collection of screening specimens: a prospective audit in a large UK teaching hospital. J. Hosp. Infect. 59(2), 90-95 (2005).
11. Bergmans DC, Bonten MJ, Gaillard CA et al. Indications for antibiotic use in icu patients: a one-year prospective surveillance. J. Antimicrob. Chemother. 39(4), 527-535 (1997).
12. Roder BL, Nielsen SL, Magnussen P, Engquist A, Frimodt-Moller N. Antibiotic usage in an intensive care unit in a danish university hospital. J. Antimicrob. Chemother. 32(4), 633-642 (1993).
13. Herzig SJ, Howell MD, Ngo LH, Marcantonio ER. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA 301(20), 2120-2128 (2009).
14. Dubberke ER, Reske KA, Yan Y, Olsen MA, Mcdonald LC, Fraser VJ. Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin. Infect. Dis. 45(12), 1543-1549 (2007).
15. Berriel-Cass D, Adkins FW, Jones P, Fakih MG. Eliminating nosocomial infections at Ascension Health. Jt Comm. J. Qual. Patient Saf. 32(11), 612-620 (2006).
16. Apisarnthanarak A, Pinitchai U, Thongphubeth K et al. Effectiveness of an educational program to reduce ventilator-associated pneumonia in a tertiary care center in Thailand: a 4-year study. Clin. Infect. Dis. 45(6), 704-711 (2007).
17. Zilberberg MD, Shorr AF, Kollef MH. Implementing quality improvements in the intensive care unit: ventilator bundle as an example. Crit. Care Med. 37(1), 305-309 (2009).
18. Blamoun J, Alfakir M, Rella ME et al. Efficacy of an expanded ventilator bundle for the reduction of ventilator-associated pneumonia in the medical intensive care unit. Am. J. Infect. Control 37(2), 172-175 (2009).
19. Cocanour CS, Peninger M, Domonoske BD et al. Decreasing ventilator associated pneumonia in a trauma ICU. J. Trauma 61(1), 122-129; discussion 129-130 (2006).
20. Hawe CS, Ellis KS, Cairns CJ, Longmate A. Reduction of ventilator-associated pneumonia: active versus passive guideline implementation. Intens. Care Med. 35(7), 1180-1186 (2009).
21. Rello J, Lode H, Cornaglia G, Masterton R. A European care bundle for prevention of ventilator-associated pneumonia. Intens. Care Med. 36(5), 773-780 (2010).
22. Klompas M. Does this patient have ventilator-associated pneumonia? JAMA 297(14), 1583-1593 (2007).
23. Morris AC, Kefala K, Simpson AJ et al. Evaluation of the effect of diagnostic methodology on the reported incidence of ventilator-associated pneumonia. Thorax 64(6), 516-522 (2009).
24. Petersen IS, Aru A, Skodt V et al. Evaluation of pneumonia diagnosis in intensive care patients. Scand. J. Infect. Dis. 31(3), 299-303 (1999).
25. Louthan FB, Meduri GU. Differential diagnosis of fever and pulmonary densities in mechanically ventilated patients. Semin. Respir. Infect. 11(2), 77-95 (1996).
26. Meduri GU, Mauldin GL, Wunderink RG et al. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest 106(1), 221-235 (1994).
27. Rouby JJ, Rossignon MD, Nicolas MH et al. A prospective study of protected bronchoalveolar lavage in the diagnosis of nosocomial pneumonia. Anesthesiology 71(5), 679-685 (1989).
28. Balthazar AB, Von Nowakonski A, De Capitani EM, Bottini PV, Terzi RG, Araujo S. Diagnostic investigation of ventilator-associated pneumonia using bronchoalveolar lavage: comparative study with a postmortem lung biopsy. Braz. J. Med. Biol. Res. 34(8), 993-1001 (2001).
29. Bregeon F, Papazian L, Thomas P et al. Diagnostic accuracy of protected catheter sampling in ventilator-associated bacterial pneumonia. Eur. Respir. J. 16(5), 969-975 (2000).
30. Tejerina E, Esteban A, Fernandez- Segoviano P et al. Accuracy of clinical definitions of ventilator-associated pneumonia: comparison with autopsy findings. J. Crit. Care 25(1), 62-68 (2010).
31. Kirtland SH, Corley DE, Winterbauer RH et al. The diagnosis of ventilator-associated pneumonia: a comparison of histologic, microbiologic, and clinical criteria. Chest 112(2), 445-457 (1997).
32. Fabregas N, Ewig S, Torres A et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 54(10), 867-873 (1999).
33. Papazian L, Thomas P, Garbe L et al. Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 152(6 Pt 1), 1982-1991 (1995).
34. Marquette CH, Copin MC, Wallet F et al. Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am. J. Respir. Crit. Care Med. 151(6), 1878-1888 (1995).
35. Torres A, El-Ebiary M, Padro L et al. Validation of different techniques for the diagnosis of ventilator-associated pneumonia. Comparison with immediate postmortem pulmonary biopsy. Am. J. Respir. Crit. Care Med. 149(2 Pt 1), 324-331 (1994).
36. Chastre J, Viau F, Brun P et al. Prospective evaluation of the protected specimen brush for the diagnosis of pulmonary infections in ventilated patients. Am. Rev. Resp. Dis. 130(5), 924-929 (1984).
37. Klompas M. The paradox of ventilator-associated pneumonia prevention measures. Crit. Care (London, England) 13(5), 315 (2009).
38. Klompas M, Platt R. Ventilator-associated pneumonia - the wrong quality measure for benchmarking. Ann. Intern. Med. 147(11), 803-805 (2007).
39. American Thoracic Society and Infectious Diseases Society of America: guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 171(4), 388-416 (2005).
40. Coffin SE, Klompas M, Classen D et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect. Control Hosp. Epidemiol. 29(Suppl. 1), S31-S40 (2008).
41. Torres A, Ewig S, Lode H, Carlet J. Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med. 35(1), 9-29 (2009).
42. Torres A, Serra-Batlles J, Ros E et al. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann. Intern. Med. 116(7), 540-543 (1992).
43. Kollef MH. Ventilator-associated pneumonia. A multivariate analysis. JAMA 270(16), 1965-1970 (1993).
44. Drakulovic MB, Torres A, Bauer TT, Nicolas JM, Nogue S, Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 354(9193), 1851-1858 (1999).
45. Van Nieuwenhoven CA, Vandenbroucke- Grauls C, Van Tiel FH et al. Feasibility and effects of the semirecumbent position to prevent ventilator-associated pneumonia: a randomized study. Crit. Care Med. 34(2), 396-402 (2006).
46. Johanson WG, Pierce AK, Sanford JP. Changing pharyngeal bacterial flora of hospitalized patients. Emergence of Gram-negative bacilli. N. Engl. J. Med. 281(21), 1137-1140 (1969).
47. Johanson WG Jr, Pierce AK, Sanford JP, Thomas GD. Nosocomial respiratory infections with Gram-negative bacilli. The significance of colonization of the respiratory tract. Ann. Intern. Med. 77(5), 701-706 (1972).
48. Johanson WG, Dever LL. Nosocomial pneumonia. Intens. Care Med. 29(1), 23-29 (2003).
49. Mahul P, Auboyer C, Jospe R et al. Prevention of nosocomial pneumonia in intubated patients: respective role of mechanical subglottic secretions drainage and stress ulcer prophylaxis. Intens. Care Med. 18(1), 20-25 (1992).
50. Mahul P, Auboyer C, Jospe R et al. Prevention of nosocomial pneumonia in intubated patients: respective role of mechanical subglottic secretions drainage and stress ulcer prophylaxis. Intensive Care Med. 18(1), 20-25 (1992).
51. Valles J, Artigas A, Rello J et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann. Intern. Med. 122(3), 179-186 (1995).
52. Kollef MH, Skubas NJ, Sundt TM. A randomized clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patients. Chest 116(5), 1339-1346 (1999).
53. Smulders K, Van Der Hoeven H, Weers-Pothoff I, Vandenbroucke-Grauls C. A randomized clinical trial of intermittent subglottic secretion drainage in patients receiving mechanical ventilation. Chest 121(3), 858-862 (2002).
54. Bouza E, Perez MJ, Munoz P, Rincon C, Barrio JM, Hortal J. Continuous aspiration of subglottic secretions in the prevention of ventilator-associated pneumonia in the postoperative period of major heart surgery. Chest 134(5), 938-946 (2008).
55. Lorente L, Lecuona M, Jimenez A, Mora ML, Sierra A. Influence of an endotracheal tube with polyurethane cuff and subglottic secretion drainage on pneumonia. Am. J. Respir. Crit. Care Med. 176(11), 1079-1083 (2007).
56. Yang CS, Qiu HB, Zhu YP et al. [Effect of continuous aspiration of subglottic secretions on the prevention of ventilator-associated pneumonia in mechanically ventilated patients: a prospective, randomized, controlled clinical trial]. Zhonghua Nei Ke Za Zhi 47(8), 625-629 (2008).
57. Zheng RQ, Lin H, Shao J et al. [A clinical study of subglottic secretion drainage for prevention of ventilation associated pneumonia]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 20(6), 338-340 (2008).
58. Dezfulian C, Shojania K, Collard HR et al. Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis. Am. J. Med. 118(1), 11-18 (2005).
59. Kollef MH, Afessa B, Anzueto A et al. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the nascent randomized trial. JAMA 300(7), 805-813 (2008).
60. Klompas M. Silver-coated endotracheal tubes and patient outcomes in ventilator-associated pneumonia. JAMA 300(22), 2605; author reply 2605-2606 (2008).
61. Falagas ME, Siempos II, Bliziotis IA, Michalopoulos A. Administration of antibiotics via the respiratory tract for the prevention of icu-acquired pneumonia: a meta-analysis of comparative trials. Crit. Care (London, England) 10(4), R123 (2006).
62. Seguin P, Tanguy M, Laviolle B, Tirel O, Malledant Y. Effect of oropharyngeal decontamination by povidone-iodine on ventilator-associated pneumonia in patients with head trauma. Crit. Care Med. 34(5), 1514-1519 (2006).
63. Kollef M, Pittet D, Sanchez Garcia M et al. A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 173(1), 91-97 (2006).
64. Fourrier F, Cau-Pottier E, Boutigny H, Roussel-Delvallez M, Jourdain M, Chopin C. Effects of dental plaque antiseptic decontamination on bacterial colonization and nosocomial infections in critically ill patients. Intensive Care Med. 26(9), 1239-1247 (2000).
65. Genuit T, Bochicchio G, Napolitano LM, Mccarter RJ, Roghman MC. Prophylactic chlorhexidine oral rinse decreases ventilator-associated pneumonia in surgical ICU patients. Surg. Infect. 2(1), 5-18 (2001).
66. Segers P, Speekenbrink RG, Ubbink DT, Van Ogtrop ML, De Mol BA. Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial. JAMA 296(20), 2460-2466 (2006).
67. Deriso AJ 2nd, Ladowski JS, Dillon TA, Justice JW, Peterson AC. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest 109(6), 1556-1561 (1996).
68. Houston S, Hougland P, Anderson JJ, Larocco M, Kennedy V, Gentry LO. Effectiveness of 0.12% chlorhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery. Am. J. Crit. Care 11(6), 567-570 (2002).
69. Fourrier F, Dubois D, Pronnier P et al. Effect of gingival and dental plaque antiseptic decontamination on nosocomial infections acquired in the intensive care unit: a double-blind placebo-controlled multicenter study. Crit. Care Med. 33(8), 1728-1735 (2005).
70. Koeman M, Van Der Ven AJ, Hak E et al. Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 173(12), 1348-1355 (2006).
71. Tantipong H, Morkchareonpong C, Jaiyindee S, Thamlikitkul V. Randomized controlled trial and meta-analysis of oral decontamination with 2% chlorhexidine solution for the prevention of ventilator-associated pneumonia. Infect. Control Hosp. Epidemiol. 29(2), 131-136 (2008).
72. Bellissimo-Rodrigues F, Bellissimo-Rodrigues WT, Viana JM et al. Effectiveness of oral rinse with chlorhexidine in preventing nosocomial respiratory tract infections among intensive care unit patients. Infect. Control Hosp. Epidemiol. 30(10), 952-958 (2009).
73. Panchabhai TS, Dangayach NS, Krishnan A, Kothari VM, Karnad DR. Oropharyngeal cleansing with 0.2% chlorhexidine for prevention of nosocomial pneumonia in critically ill patients: an open-label randomized trial with 0.01% potassium permanganate as control. Chest 135(5), 1150-1156 (2009).
74. Scannapieco FA, Yu J, Raghavendran K et al. A randomized trial of chlorhexidine gluconate on oral bacterial pathogens in mechanically ventilated patients. Crit. Care (London, England) 13(4), R117 (2009).
75. Chan EY, Ruest A, Meade MO, Cook DJ. Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis. Br. Med. J. (Clin.Res. Ed.) 334(7599), 889 (2007).
76. Heo SM, Haase EM, Lesse AJ, Gill SR, Scannapieco FA. Genetic relationships between respiratory pathogens isolated from dental plaque and bronchoalveolar lavage fluid from patients in the intensive care unit undergoing mechanical ventilation. Clin. Infect. Dis. 47(12), 1562-1570 (2008).
77. Siempos II, Ntaidou TK, Falagas ME. Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit. Care Med. 38(3), 954-962 (2010).
78. Van Nieuwenhoven CA, Buskens E, Van Tiel FH, Bonten MJ. Relationship between methodological trial quality and the effects of selective digestive decontamination on pneumonia and mortality in critically ill patients. JAMA 286(3), 335-340 (2001).
79. Silvestri L, Van Saene HK, Milanese M, Gregori D, Gullo A. Selective decontamination of the digestive tract reduces bacterial bloodstream infection and mortality in critically ill patients. Systematic review of randomized, controlled trials. J. Hosp. Infect. 65(3), 187-203 (2007).
80. De Smet AM, Kluytmans JA, Cooper BS et al. Decontamination of the digestive tract and oropharynx in icu patients. N. Engl. J. Med. 360(1), 20-31 (2009).
81. Oostdijk EA, De Smet AM, Blok HE et al. Ecological effects of selective decontamination on resistant Gram-negative bacterial colonization. Am. J. Respir. Crit. Care Med. 181(5), 452-457 (2010).
82. Ely EW, Baker AM, Dunagan DP et al. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N. Engl. J. Med. 335(25), 1864-1869 (1996).
83. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N. Engl. J. Med. 342(20), 1471-1477 (2000).
84. Girard TD, Kress JP, Fuchs BD et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (awakening and breathing controlled trial): a randomised controlled trial. Lancet 371(9607), 126-134 (2008).
85. Wip C, Napolitano L. Bundles to prevent ventilator-associated pneumonia: how valuable are they? Curr. Opin. Infect. Dis. 22(2), 159-166 (2009).
86. Van Saene HK, Silvestri L, De La Cal MA, Baines P. The emperor's new clothes: the fairy tale continues. J. Crit. Care 24(1), 149-152 (2009).
87. Zilberberg MD, Shorr AF, Kollef MH. Implementing quality improvements in the intensive care unit: ventilator bundle as an example. Crit. Care Med. 37(1), 305-309 (2009).
88. Klompas M. Interobserver variability in ventilator-associated pneumonia surveillance. Am. J. Infect. Control 38(3), 237-239 (2010).
89. Burger CD, Resar RK. "Ventilator bundle" approach to prevention of ventilator-associated pneumonia. Mayo Clin. Proc. 81(6), 849-850 (2006).
90. Lansford T, Moncure M, Carlton E et al. Efficacy of a pneumonia prevention protocol in the reduction of ventilator-associated pneumonia in trauma patients. Surg. Infect. 8(5), 505-510 (2007).
91. Bloos F, Muller S, Harz A et al. Effects of staff training on the care of mechanically ventilated patients: a prospective cohort study. Br. J. Anaesth. 103(2), 232-237 (2009).
92. Crunden E, Boyce C, Woodman H, Bray B. An evaluation of the impact of the ventilator care bundle. Nurs. Crit. Care 10(5), 242-246 (2005).
93. Robb E, Jarman B, Suntharalingam G, Higgens C, Tennant R, Elcock K. Using care bundles to reduce in-hospital mortality: quantitative survey. Br. Med. J. (Clin. Res. Ed.) 340, c1234 (2010).
94. Falagas ME, Kouranos VD, Michalopoulos A, Rodopoulou SP, Athanasoulia AP, Karageorgopoulos DE. Inadequate statistical power of published comparative cohort studies on ventilator-associated pneumonia to detect mortality differences. Clin. Infect. Dis. 50(4), 468-472 (2010).
95. Klompas M, Khan Y, Kleinman K et al. Multicenter evaluation of a novel surveillance definition for complications of mechanical ventilation (abstract 741). Presented at: Society for Healthcare Epidemiology of America and the Association of Professionals in Infection Control, Fifth Decennial Meeting. GA, USA, 18-22 March 2010.